Geneva, Aug. 31 -- International Clinical Trials Registry received information related to the study (NCT07779005) titled 'The Shengjing Lung Cancer Cohort (SJ-LCC) Study on Risk Factors for Disease Development and Progression' on Aug. 19.

Study Type: Observational [Patient Registry]

Primary Sponsor: Shengjing Hospital

Condition: Lung Caner

Recruitment Status: Recruiting

Date of First Enrollment: February 1, 2019

Target Sample Size: 1500

Countries of Recruitment: China

To know more, visit https://clinicaltrials.gov/study/NCT07779005

Disclaimer: Curated by HT Syndication....